Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care

• Autors principals: Cosimo Galletti (Autor), Maria Antonietta Barbieri (Autor), Francesco Ciodaro (Autor), Francesco Freni (Autor), Francesco Galletti (Autor), Edoardo Spina (Autor), Bruno Galletti (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2023-04-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a type 2 pattern of inflammation resulting in the production of some cytokines. Dupilumab radically changes the treatment of CRSwNP, but, considering its recent approval, it may be useful to evaluate its safety profile in a real-w...